Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$16.64 USD
+0.13 (0.79%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $16.65 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Cellebrite DI Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.10 | 120.81 | 71.40 | -0.18 | -1.88 |
Depreciation/Amortization & Depletion | 8.91 | 8.82 | 7.01 | 0.00 | 4.08 |
Net Change from Assets/Liabilities | 38.52 | -2.82 | 20.68 | -0.25 | 2.84 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 135.73 | -106.23 | -63.03 | -0.05 | 11.09 |
Net Cash From Operating Activities | 102.06 | 20.58 | 36.05 | -0.49 | 16.13 |
Property & Equipment | -5.23 | -6.90 | -5.11 | 0.00 | -6.21 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -20.00 | 0.00 | 0.00 |
Investments | -14.62 | -82.15 | 73.34 | 0.00 | -40.51 |
Other Investing Activities | -2.69 | -2.19 | -3.00 | -600.00 | 0.00 |
Net Cash from Investing Activities | -22.54 | -91.23 | 45.23 | -600.00 | -46.72 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 21.77 | 13.97 | 2.31 | 600.03 | 100.54 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | -100.00 | 0.00 | -25.00 |
Other Financing Activities | 0.00 | 0.00 | 29.30 | 1.95 | 0.00 |
Net Cash from Financing Activities | 21.77 | 13.97 | -68.40 | 601.97 | 75.54 |
Effect of Exchange Rate Changes | 0.59 | -1.64 | -0.75 | 0.00 | -0.07 |
Net Change In Cash & Equivalents | 101.87 | -58.33 | 12.13 | 1.48 | 44.88 |
Cash at Beginning of Period | 87.65 | 145.97 | 133.85 | 0.00 | 36.80 |
Cash at End of Period | 189.52 | 87.65 | 145.97 | 1.48 | 81.68 |
Diluted Net EPS | -0.43 | 0.59 | 0.44 | -0.01 | NA |
Fiscal Year End for Cellebrite DI Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -95.18 | -71.37 | -81.10 | -66.45 | -72.95 |
Depreciation/Amortization & Depletion | 3.95 | 2.13 | 8.91 | 6.60 | 4.56 |
Net Change from Assets/Liabilities | -9.85 | -4.80 | 38.52 | 17.12 | 11.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 125.63 | 84.08 | 135.73 | 100.96 | 86.08 |
Net Cash From Operating Activities | 24.55 | 10.04 | 102.06 | 58.23 | 29.05 |
Property & Equipment | -3.57 | -1.50 | -5.23 | -2.97 | -1.89 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -110.39 | -79.48 | -14.62 | -22.73 | -12.92 |
Other Investing Activities | -0.90 | -0.63 | -2.69 | 0.00 | 0.00 |
Net Cash from Investing Activities | -114.86 | -81.60 | -22.54 | -25.70 | -14.81 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 8.39 | 5.07 | 21.77 | 17.24 | 8.42 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 8.39 | 5.07 | 21.77 | 17.24 | 8.42 |
Effect of Exchange Rate Changes | -0.65 | -0.60 | 0.59 | -0.34 | 0.19 |
Net Change In Cash & Equivalents | -82.56 | -67.09 | 101.87 | 49.42 | 22.86 |
Cash at Beginning of Period | 189.52 | 189.52 | 87.65 | 87.65 | 87.65 |
Cash at End of Period | 106.96 | 122.43 | 189.52 | 137.07 | 110.50 |
Diluted Net EPS | -0.12 | -0.36 | -0.08 | 0.03 | -0.17 |